Galecto, Inc. — Director's Dealing 2020

Oct 29, 2020

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Galecto Inc. (GLTO)
CIK: 0001800315
Period of Report: 2020-10-28

Reporting Person: Lindmark Bertil (Chief Medical Officer)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$1.95	2030-06-24	Common Stock (174179)		Direct

Footnotes

F1: 25% of the shares subject to such option vest and become exercisable February 1, 2021 and the remainder of the shares vest in substantially equal monthly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date.